We have developed the device recorded the neuronal action potential of multiple mouse brainstheir cerebellum with high sampling rate (30 kHz)multiple channels to accelerate the study of the pathogenesis of neurodegenerative diseases. The team hopes to extend the multi-channel BCI devicebrainwave technology to more neurodegenerative disease biomarker analysis to help pharmaceutical companies to explore the pathogenesis of neurodegenerative diseaseshelp in new drug developmentclinical diagnosis.

In wireless brain-machine interface devices (BCI), the solution to bandwidth limitations has become one of the key points that would lead to the breakthrough in brain science development. Insufficient bandwidth cannot satisfy the demand of high-speed transmission between brainmachine, which would limit the availabilityuniversality of brain-machine interface. Currently, there is a lack of wireless products with reasonable performance to measure neuronal action potentials,thus, animal experiments are forced to adopt wired experiments.

According to the U.S. allied market research report, the relevant market size for brain computer interface will be US$1.36 billion in 2019is expected to reach US$3.85 billion in 2027, with a compound annual growth rate of 14.3 from 2020 to 2027. In the future, brain-machine interface technology can be applied to medical, education, sports, entertainment, games, communication,other fields, proving its great market potential.

天使投資人、策略合作夥伴